products, and D-dimer levels correlated well with mortality in patients with traumatic brain injury. 9, 10 Furthermore, an increased INR is associated with poor clinical outcomes in critically ill patients with hypoxic hepatitis. 11, 12 However, data on the prognostic utility of coagulation parameters in acute PE patients not on anticoagulant therapy are scarce. Wong et al. 13 study is the only study to date demonstrating the prognostic significance of admission INR in acute PE patients, and did not include assessing white blood cell (WBC) and right ventricular dysfunction. The present study validates and also addresses potential mechanisms of elevated INR in acute PE.
| MATERIALS AND METHODS
This retrospective study analyzed 272 patients with acute PE diagnosed by CTPA in our hospital between April 2008 and January 2015. Exclusion criteria included patients under age 18, those who had received previous anticoagulant therapy (warfarin, enoxaparin, and/or novel oral anticoagulants, including dabigatran, rivaroxaban, and apixaban), patients with any underlying disease limiting their estimated life expectancy to less than 1 month (major trauma), those with hematological disorders, infectious or inflammatory diseases, or serious renal and liver diseases, patients who were documented to be on immunosuppressant therapy (including steroids), and those with incomplete documentation. Twenty-eight patients were excluded from the study, as follows: two patients had end-stage cancer, two had serious renal disease, three had a history of serious liver failure, one had septic shock, one was on immunosuppressant therapy, one had a hematological disorder, one had a closed traumatic brain injury, seven had incomplete data, and 10 had received anticoagulant therapy. The remaining 244 patients (146 patients were diagnosed with acute PE in Emergency Department, 88 patients were diagnosed with acute PE in Ward/Intensive Care Unit during hospital stay) composed the final study population. Data on clinical and demographic characteristics and laboratory parameters were collected from medical records.
Patients were grouped as survivors and non-survivors. The study protocol was approved by the local ethics committee (the number of the local ethics committee: 321). RVd/LVd ratio (RVd/LVd) was calculated, and ratios over 0.9 were considered as right ventricular dysfunction (RVD). CBC was determined via a Abbott Cell-Dyn 3700 autoanalyzer using commercial assay kits (Abbott Diagnostic, Santa Clara, CA, USA). Biochemical measurements were performed using Siemens Healthcare Diagnostic
| Definitions
Products kits and calibrators (Marburg, Germany).
| Medications
In the present study, 17.6% of the patients received a thrombolytic treatment, including a tissue plasminogen activator or streptokinase.
After the diagnosis of acute PE was ascertained, low-molecular weight heparin (LMWH) was given subcutaneously at weight-adjusted doses.
After the thrombolytic treatment, intravenous unfractionated heparin (UFH) or subcutaneous LMWH was used. Warfarin therapy was given to patients without active cancer on the day of admission, except for those who were treated with thrombolytic therapy; in this case, they were treated with warfarin 24 hours after thrombolytic therapy.
Patients who received warfarin treatment were discharged with appropriate INR levels of 2-3. Patients with cancer were prescribed weight-adjusted LMWH at discharge.
| Statistical analysis
Continuous variables were presented as mean values±SD or medians with ranges, and categorical variables were expressed as percentages.
Variables were compared by a two-tailed Student's t test for continu- software programme. Moreover, the increased discriminative value after the addition of INR to sPESI score was also estimated using the Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement. 18 Survival curves were generated using the KaplanMeier method, and the log-rank test was used to compare survival between the groups. All statistical tests were two-tailed, and a P value <.05 was considered statistically significant. All analyses were performed using SPSS version 15 (SPSS, Inc.; Chicago, IL, USA). Figure 2 ).
| RESULTS
The addition of INR to s PESI score was related to a significant NRI of 8.8% (P<.001), and an IDI of 0.043 (P=.027; Table 5 ).
In subgroup analysis, we compared the prognostic value of INR between patients who were diagnosed with PE in Emergency 
| DISCUSSION
The results of the present study found that INR was significantly higher in non-survivors than in survivors. In addition, elevated INR in the absence of anticoagulant therapy was independently associated with 30-day mortality, as were sPESI score, RVD, WBC, and altered mental status. Consistent with the results of the present study, prior studies have shown that elevated sPESI scores, altered mental status, and RVD were associated with increased mortality rates in acute PE. 8, 19, 20 Although PT and aPTT poorly reflect in vivo hemostasis, they are commonly used to evaluate coagulation state. 21 However, these tests are a convenient method to quickly estimate the concentration of one or at times multiple coagulation factors for which each test is sensitive. 22 In general, global clotting test results become elevated when the levels of clotting factors decrease to less than 50%. This is relevant since the levels of coagulation factors, that are needed for adequate hemostasis, are somewhere between 25% and 50%. 21 An elevated INR may result from factor VII deficiency, mild vitamin K deficiency, mild liver insufficiency, or lower doses of vitamin K antagonists. In the vast majority of critically ill patients, deficiencies in coagulation factors are acquired. 23 In most other cases, deficiencies in coagulation factors are caused by impaired synthesis, massive loss, or increased turnover (consumption).
Activating the inflammatory and coagulation pathways plays an important role in the pathogenesis of vascular diseases. 24 Growing evidence shows that these two systems have a cross-talk relationship, in which one can trigger the other. In general, endothelial cells play a central role in the coagulation response to systemic inflammation. 24 In acute thromboembolic events, thrombin can have a pro-inflammatory effect. 25 Activation of the coagulation system and increased inflammation may lead to consumptive coagulopathy.
In addition, the WBC count is correlated with the levels of hemostatic parameters. 26 Furthermore, it is likely that severe PE alone may cause an elevated INR by inducing consumptive coagulopathy or disseminated intravascular coagulation (DIC). 27 Central pulmonary embolism with a higher thrombi burden could also lead to a higher degree of hypoxemia. 28 This may activate the inflammatory pathways favoring the larger emboli. 27 In the present study, INR was positively correlated with WBC count. In addition, the rate of the centrally lodged thrombi was higher in non-survivors than survivors. History of Stroke/TIA, n (%) 27 (13) 5 (13) .990
Heart failure, n (%) 11 (5) 1 (3) .458
CAD, n (%) 22 (11) 1 (3) .117
Smoking, n (%) 19 (9) 5 (13) .495
Recent surgery, n (%) 73 (36) 12 (31) .561
Altered mental status, n (%) 0 (0) 4 (10) <.001
Syncope, n (%) 12 (6) T-wave inversion (V1-3), n (%) 19 (8) 3 (6) .692
RBBB, n (%)
11 (4) 6 (2) .848
Thrombolytic treatment, n (%) 38 (19) 5 (13) .390
CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; TIA, transient ischemic attack; sPAP, Systolic pulmonary arterial pressure; sPESI, simplified pulmonary embolism severity index; MPA, main pulmonary arteries; PE, pulmonary emboli; RBBB, right bundle-branch block; RVD, right ventricular dysfunction. Acute PE can cause right-heart failure, which leads to hepatic insufficiency or hypoxic hepatitis. 30 Elevated right-side pressure, in turn, leads to hepatic congestion, which may affect the production of coagulation factors. A previous study categorized PE patients into four groups according to arterial partial oxygen pressure, presence of massive or sub-massive PE, pre-existing cardiopulmonary disease, and presence of RVD. 31 The study compared liver enzymes and PT among the four groups and found that aspartat transaminase (AST) and ALT levels were higher in cases of massive PE than in non-massive cases. In contrast, in a study by Rendina et al., 32 the PT did not differ between the RVD and non-RVD groups. However, the present study did not routinely measure other hepatic tests, such as alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT), and bilirubin, but it did find a weak positive relationship between INR and ALT levels. Therefore, we believe that hepatic dysfunction may also be responsible for elevated INR in some PE patients.
Early death after PE is strongly associated with RVD or RV dilatation. 19 Animal studies and human autopsies have shown that acute PE with pulmonary hypertension in both rats and humans has resulted in right ventricular myocyte lysis and infiltration by neutrophils, macrophages, and lymphocytes 33, 34 after which such inflammation may trigger injury, leading to increased cTnI levels associated with mortality. 35 Elevated WBC and neutrophil counts may reflect PE-related RVD. 19 Also, higher WBC count is associated with mortality in a previous study by Venetz et al. 36 as found in our study.
Furthermore, INR was positively correlated with RV dimensions in
the present study.
A previous study showed that critically ill patients may have some hemostatic abnormalities, including prolonged PT, INR, and aPTT. 23 Fei et al. 37 reported that PT/INR, and aPTT were more significantly prolonged in non-survivors than in survivors who were hospitalized in an intensive care unit. They also found that a INR of 1.07 seconds was the cut-off point for predicting in-hospital mortality with a sensitivity of 85% and a specificity of 49%. Okada et al. 38 showed that increased INR was associated with future adverse events in acute, decompensated heart failure. Our findings are in agreement with the abovementioned studies' results, in which prolonged PT and increased INR were associated with mortality.
Another study, which has been recently published first study on the prognostic significance of admission INR in acute PE, found that patients with acute PE who had INRs greater than 1.2 in the absence of INR, international normalized ratio; sPAP; systolic pulmonary artery pressure; ALT, alanine aminotransferase; sPESI, simplified pulmonary embolism severity index; cTnI, cardiac troponin I; WBC, white blood cell.
anticoagulant use had higher mortality during a 6-month follow-up.
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In the same study, PT was an independent predictor of 6-month mortality. 17 The PE cohort in our study were high-risk patients as reflected by the high proportions of patients with sPESI ≥1, the high proportions of clot burdens seen in the main pulmonary artery on CTPA, and 43 out of the 244 patients received thrombolytic therapy, whereas the study by Wong et al. included mostly submassive PE. That study did not evaluate RVD or RV dilatation, which is the most common cause of early death in cases of acute PE, 19 WBC showing inflammation, or myocardial necrosis measured with higher plasma levels of troponin I, whereas, the present study examined these parameters because they are associated with mortality in acute PE. 7, 36 In addition, that study did Age, cancer history, hypoxia, heart rate, and blood pressure were not entered to the multivariate model as these parameters are included in the sPESI score calculation.
not investigate ALT levels representing hepatic injury or sPAP associated with elevated right-side pressure leading to hepatic congestion and affecting the production of coagulation factors. In contrast, the present study evaluated the relationship of these parameters to INR in acute PE. Similarly, in contrast to the above-mentioned study, the present study examined the results of fibrinogen and D-dimer levels and investigated these parameters' relationships to INR. 
| Limitations
The present study had several limitations. First, it was retrospective. Second, the number of patients included was relatively small.
Third, the study did not routinely measure commonly used inflammatory markers, such as C-reactive protein and interleukins and, thus, did not compare INR with these inflammatory markers.
Fourth, the study did not investigate hemostatic parameters in specific types of cancer and the relationship between those parameters and the extent of the cancer and its treatment modalities.
Fifth, the study did not assay the important parameters of liver dysfunction, such as albumin, ALP, GGT, and levels of special coagulation factor. Finally, this observational study cannot show a causal relationship between INR and PE, although INR appears to be related to the severity of PE.
| CONCLUSIONS
In patients with acute PE, elevation of INR in the absence of anticoagulation was independently associated with 30-day mortality. The ease of measuring elevation of INR may make it useful for prognostication.
However, further studies are needed to implement this measurement into clinical practice and to determine whether an increase in INR can be correlated with inflammatory markers and RVD in patients with acute PE.
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